Literature DB >> 11844789

Rac1 and Cdc42 but not RhoA or Rho kinase activities are required for neurite outgrowth induced by the Netrin-1 receptor DCC (deleted in colorectal cancer) in N1E-115 neuroblastoma cells.

Xiaodong Li1, Etienne Saint-Cyr-Proulx, Klaus Aktories, Nathalie Lamarche-Vane.   

Abstract

Netrins are chemotropic guidance cues that attract or repel growing axons during development. DCC (deleted in colorectal cancer), a transmembrane protein that is a receptor for netrin-1, is implicated in mediating both responses. However, the mechanism by which this is achieved remains unclear. Here we report that Rho GTPases are required for embryonic spinal commissural axon outgrowth induced by netrin-1. Using N1E-115 neuroblastoma cells, we found that both Rac1 and Cdc42 activities are required for DCC-induced neurite outgrowth. In contrast, down-regulation of RhoA and its effector Rho kinase stimulates the ability of DCC to induce neurite outgrowth. In Swiss 3T3 fibroblasts, DCC was found to trigger actin reorganization through activation of Rac1 but not Cdc42 or RhoA. We detected that stimulation of DCC receptors with netrin-1 resulted in a 4-fold increase in Rac1 activation. These results implicate the small GTPases Rac1, Cdc42, and RhoA as essential components that participate in signaling the response of axons to netrin-1 during neural development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844789     DOI: 10.1074/jbc.M109913200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Molecular control of neuronal migration.

Authors:  Hwan Tae Park; Jane Wu; Yi Rao
Journal:  Bioessays       Date:  2002-09       Impact factor: 4.345

Review 2.  Cellular responses to extracellular guidance cues.

Authors:  Anastacia Berzat; Alan Hall
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

Review 3.  Signaling from axon guidance receptors.

Authors:  Greg J Bashaw; Rüdiger Klein
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-24       Impact factor: 10.005

4.  Differential modulation of drug-induced structural and functional plasticity of dendritic spines.

Authors:  Eric C Miller; Lei Zhang; Benjamin W Dummer; Desmond R Cariveau; Horace Loh; Ping-Yee Law; Dezhi Liao
Journal:  Mol Pharmacol       Date:  2012-05-17       Impact factor: 4.436

5.  Regulation of netrin-1 receptors by amphetamine in the adult brain.

Authors:  L Yetnikoff; C Labelle-Dumais; C Flores
Journal:  Neuroscience       Date:  2007-10-10       Impact factor: 3.590

6.  Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse.

Authors:  Matthew Brown; Tom Jacobs; Britta Eickholt; Giovanna Ferrari; Mabel Teo; Clinton Monfries; Robert Z Qi; Thomas Leung; Louis Lim; Christine Hall
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

7.  MARCKS Is Necessary for Netrin-DCC Signaling and Corpus Callosum Formation.

Authors:  J J Brudvig; J T Cain; G G Schmidt-Grimminger; D J Stumpo; K J Roux; P J Blackshear; J M Weimer
Journal:  Mol Neurobiol       Date:  2018-03-15       Impact factor: 5.590

Review 8.  Axon guidance: asymmetric signaling orients polarized outgrowth.

Authors:  Christopher C Quinn; William G Wadsworth
Journal:  Trends Cell Biol       Date:  2008-10-24       Impact factor: 20.808

9.  c-Jun N-terminal kinase 1 (JNK1) is required for coordination of netrin signaling in axon guidance.

Authors:  Chao Qu; Weiquan Li; Qiangqiang Shao; Trisha Dwyer; Huai Huang; Tao Yang; Guofa Liu
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

10.  Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord.

Authors:  Philip Duffy; Andre Schmandke; Antonio Schmandke; Jonathan Sigworth; Shuh Narumiya; William B J Cafferty; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.